|
References
1. Solomon D, Davey D, Kurman R, Moriarty A et al. The 2001 Bethesda System-terminology for reporting results of cervical cytology. JAMA 2002;287(16):2114-2119. Consensus Statement.
2. Popadiuk C, Francis P. Pap smears: A review of what's new. The Canadian Journal of CME, 10/2002. Available at: http://www.stacommunications.com/journals/cme/images/cmepdf/cmeoct02/papsmear.pdf. Last accessed July 16, 2003.
3. Saslow D, Runowicz CD, Solomon D, Moscicki A-B et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA-A Journal for Clinicians 2002;52(6):342-61. Available at: http://caonline.amcancersoc.org/cgi/reprint/52/6/342.pdf. Last accessed July 16, 2003.
4. Arbyn M, Schenck U. Detection of false negative Pap smears by rapid reviewing. A metaanalysis. Acta Cytol 2000;44(6):949-57.
5. Khalbuss WE, Rudomania D, Kauff ND, et al. SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: Data on 791 cases. Cancer Cytopath 2000;90(3):135-142.
6. Sundeen JT, Markovic N, Thavamoney N, et al. A new biological marker improves the Pap smear. Acta Cytol 2001;45(5):814. Abstract.
7. Arbyn M, Schenck U, Ellison E, Hanselaar A. Metaanalysis of the accuracy of rapid prescreening relative to full screening of Pap smears. Cancer Ccytopath 2003;99(1):9-16.
8. American Society of Cytopathology. Cervical cytology practice guidelines. Acta Cytol 2001;45(2):201-226.
9. Solomon D, Schiffman M, Tarone R - for the ALTS Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results form a randomized trial. JNCI 2001;93(4):293-299.
10. FDA News. FDA approves expanded use of HPV test. March 31, 2003. Available at: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html. Last accessed July 13, 2003.
11. Cytyc receives FDA approval for ThinPrep Imaging System. Cytyc June 9, 2003 press release. Available at: http://ir.cytyc.com/ReleaseDetail.cfm?ReleaseID=110980. Last accessed July 13, 2003.
12. CLIA regulations available at: 1) http://www.phppo.cdc.gov/clia/pdf/42cfr49302.pdf [123 pages] 2) http://www.phppo.cdc.gov/clia/pdf/CMS-2226-F.pdf [76 pages]. Last accessed July 13, 2003.
13. Weynaud B, Berliere M, Haumont E, et al. A new liquid-based cytology technique. Acta Cytol 2003;47(2):149-153.
14. el Hamidi A, Kocjan G, Du M-Q. Clonality analysis of archival cervical smears-correlation of monoclonality with grade and clinical behavior of cervical intraepithelial neoplasia. Act Cytol 2003;47(2):117-123.
15. Gill GW. Rapid review. Is it effective? Is it efficient? SCAN 2002;13(1):8-11.
16. U.S. Preventive Services Task Force. Screening for cervical cancer-recommendations and rationale. Available at: http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.htm. Last accessed July 13, 2003.
17. Wright TC, Cox JT, Massad LS, Twiggs LB, et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287(16):2120-9. Consensus Statement.
18. To be posted after July 2003 release at: http://www.asccp.org/consensus/histological.shtml.
19. Ethicon-Polartechnics Alliance. Available at: http://polartechnics.com.au/news/Archives/ethicon.htm.
20. What is PapSure®? Available at: http://www.papsure.com/what_is_papsure.asp. Last accessed July 13, 2003.
21. Molecular Diagnostics. InPathT System. Available at: http://www.molecular-dx.com/2_laboratorians/2_inpath/index.html. Last accessed July 13, 2003.
22. Muñoz N, Bosch FX, de Sanjosé S, Herrero R et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. NEJM 2003;348(6):518-27.
23. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. NEJM. 2002;347(21):1645-51.
24. McCory DC, Mather DB, Bastian L, et al. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment No. 5. (Prepared by Duke University under Contract No. 290-97-0014.) AHCPR Publication No. 99-E010. Rockville MD: Agency for Health Care Policy and Research. February 1999.
25. Hartmann KE, Nanda aK, Hall S, Myers E. Technologic advances for evaluation of cervical cytology: Is newer better? Obstet Gynecol Survey 2001;56(12):765-774.
26. The Doctors Company. Risk management guidelines for cervical cytology. Available at: https://secure.thedoctors.com/sourcebook/J4200.pdf
27. Miller MG, Sung HY, Sawaya GF, et al. Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol 2003;101(1):29-37.
|